Recofol N is a Bayer-originated intravenous anaesthetic, which is used by intensive care units, surgeries and clinics.
Primex Pharmaceuticals obtained Recofol N through an acquisition from Bayer in 2012. Recofol N’s active ingredient is propofol, which is the most widely used intravenous anaesthetic. Recofol N is known for its versatility, quality, speed, and lack of uncomfortable side effects such as dizziness and post-operative nausea.
Recofol EDTA (propofol plus EDTA) is propofol with the preservative EDTA as an antimicrobial retardant, as required by the FDA and other authorities and is manufactured in EU.